$BLUE
bluebird bio, Inc.

2014 Q1 Form 10-K Financial Statement

#000119312514084683 Filed on March 05, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2013
Revenue $6.335M $6.335M $20.18M
YoY Change 462.11% 7352.94% 5835.59%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.500M $4.700M $14.10M
YoY Change 139.13% 88.0% 107.35%
% of Gross Profit
Research & Development $11.46M $9.800M $31.00M
YoY Change 116.94% 50.77% 80.14%
% of Gross Profit
Depreciation & Amortization $480.0K $330.0K $900.0K
YoY Change 242.86% 266.67% 200.0%
% of Gross Profit
Operating Expenses $17.00M $14.50M $45.13M
YoY Change 221.78% 61.11% 162.22%
Operating Profit -$10.67M -$8.115M -$24.95M
YoY Change 64.6% -9.39% 5.19%
Interest Expense $0.00 -$400.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net $59.00K -$403.0K
YoY Change -193.65% -976.09%
Pretax Income -$10.60M -$8.100M -$26.02M
YoY Change 63.08% -10.0% 9.78%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$10.61M -$8.081M -$25.32M
YoY Change 62.12% -10.19% 6.98%
Net Earnings / Revenue -167.47% -127.56% -125.47%
Basic Earnings Per Share
Diluted Earnings Per Share -$439.8K -$338.9K -$2.008M
COMMON SHARES
Basic Shares Outstanding 24.17M shares 23.78M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q4 2013
SHORT-TERM ASSETS
Cash & Short-Term Investments $192.5M $206.3M $206.3M
YoY Change 46.05% 207.91%
Cash & Equivalents $192.5M $206.3M $206.3M
Short-Term Investments $0.00
Other Short-Term Assets $3.400M $5.700M $5.700M
YoY Change 6.25% 612.5%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $195.9M $212.0M $212.0M
YoY Change 45.02% 212.74% 212.68%
LONG-TERM ASSETS
Property, Plant & Equipment $11.98M $10.92M $10.90M
YoY Change 470.67% 747.83% 738.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.600M $1.483M $1.500M
YoY Change 433.33% 400.0%
Total Long-Term Assets $13.59M $12.40M $12.40M
YoY Change 466.25% 706.44% 726.67%
TOTAL ASSETS
Total Short-Term Assets $195.9M $212.0M $212.0M
Total Long-Term Assets $13.59M $12.40M $12.40M
Total Assets $209.5M $224.4M $224.4M
YoY Change 52.37% 223.69% 223.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.601M $4.359M $4.400M
YoY Change 18.23% 100.6% 100.0%
Accrued Expenses $5.200M $4.900M $4.200M
YoY Change 246.67% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $33.05M $34.87M $34.90M
YoY Change 11.27% 653.54% 658.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $385.0K $208.0K $37.20M
YoY Change -99.22% 6100.0%
Total Long-Term Liabilities $385.0K $208.0K $37.20M
YoY Change -99.22% 6100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.05M $34.87M $34.90M
Total Long-Term Liabilities $385.0K $208.0K $37.20M
Total Liabilities $65.35M $72.72M $72.70M
YoY Change -17.49% 1290.76% 1298.08%
SHAREHOLDERS EQUITY
Retained Earnings -$109.3M -$98.68M
YoY Change 34.52%
Common Stock $243.0K $239.0K
YoY Change 7866.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $144.2M $151.7M $151.7M
YoY Change
Total Liabilities & Shareholders Equity $209.5M $224.4M $224.4M
YoY Change 52.37% 223.69% 223.81%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2013
OPERATING ACTIVITIES
Net Income -$10.61M -$8.081M -$25.32M
YoY Change 62.12% -10.19% 6.98%
Depreciation, Depletion And Amortization $480.0K $330.0K $900.0K
YoY Change 242.86% 266.67% 200.0%
Cash From Operating Activities -$11.93M -$5.460M $43.45M
YoY Change -118.07% -17.65% -306.47%
INVESTING ACTIVITIES
Capital Expenditures $2.517M -$5.290M $8.670M
YoY Change 209.98% 1369.44% 900.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$1.150M
YoY Change -133.14%
Cash From Investing Activities -$2.520M -$5.290M -$9.823M
YoY Change 211.11% 1369.44% -477.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $671.0K $376.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 670.0K 230.0K 105.6M
YoY Change -276.32% -1250.0% 76.5%
NET CHANGE
Cash From Operating Activities -11.93M -5.460M 43.45M
Cash From Investing Activities -2.520M -5.290M -9.823M
Cash From Financing Activities 670.0K 230.0K 105.6M
Net Change In Cash -13.78M -10.52M 139.3M
YoY Change -121.26% 50.07% 236.34%
FREE CASH FLOW
Cash From Operating Activities -$11.93M -$5.460M $43.45M
Capital Expenditures $2.517M -$5.290M $8.670M
Free Cash Flow -$14.45M -$170.0K $34.78M
YoY Change -122.16% -97.29% -258.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24169543 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2013Q2 blue Class Of Warrant Or Right Exercise Price Of Warrants Or Rights For First Lot
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsForFirstLot
12.55
CY2013Q2 blue Class Of Warrant Or Right Exercise Price Of Warrants Or Rights For Second Lot
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsForSecondLot
6.19
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-36083000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9350000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-55707000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25604000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
309000 shares
CY2013Q2 dei Entity Public Float
EntityPublicFloat
224772374
CY2012Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
317252000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
309000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.09
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2201000 shares
CY2012Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6512000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21089000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
215000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
527000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15267000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2173000
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
688000
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
29431000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4628000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
911000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-55747000
CY2012Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73354000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
340000
CY2012Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
215000
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
46000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2012Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
24000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69322000
CY2012Q4 us-gaap Liabilities
Liabilities
5229000
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
21000
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
340000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1910000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
67784000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
587000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34874000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
12155000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1740000
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
29431000
CY2012Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
67011000
CY2012Q4 us-gaap Assets
Assets
69322000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67011000
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1815000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
289000
CY2012Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
267000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
773000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
24044000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1288000
CY2012Q4 blue Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
471000
CY2012Q4 blue Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2115000
CY2012Q4 blue Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
2115000
CY2012Q4 blue Deferred Tax Assets Capitalized Research And Development Expenses
DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenses
2334000
CY2012Q4 blue Restricted Cash And Other Non Current Assets
RestrictedCashAndOtherNonCurrentAssets
250000
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21511000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23940000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1307000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23940000 shares
CY2013Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5296000 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.21
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3958000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.21
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
338000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3905000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.22
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2795000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1454000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
250103000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
25263000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4359000
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
305000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2739000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
40555000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
483000
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
29000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
208000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
151667000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2821000
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0
CY2013Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2596000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98675000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
25340000
CY2013Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
6740000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
239000
CY2013Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
738000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
224390000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
693000
CY2013Q4 us-gaap Liabilities
Liabilities
72723000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2659000
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
273000
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
30208000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2094000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3638000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
211987000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
659000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
43151000
CY2013Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
206279000
CY2013Q4 us-gaap Assets
Assets
224390000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
62294000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
206279000
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12374000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
24517000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
4177000
CY2013Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
21830000
CY2013Q4 us-gaap Marketable Securities
MarketableSecurities
0
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5015000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
63137000
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
10517000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
11010000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
693000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10920000
CY2013Q4 blue Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
2119000
CY2013Q4 blue Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5175000
CY2013Q4 blue Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
5175000
CY2013Q4 blue Deferred Tax Assets Capitalized Research And Development Expenses
DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenses
1837000
CY2013Q4 blue Restricted Cash And Other Non Current Assets
RestrictedCashAndOtherNonCurrentAssets
1483000
CY2013Q2 blue Letter Of Credit Related With New Lease Agreement
LetterOfCreditRelatedWithNewLeaseAgreement
1253000
CY2013Q4 blue Utilization Of Federal And State Net Operating Loss Carryforward
UtilizationOfFederalAndStateNetOperatingLossCarryforward
35400000
CY2013Q2 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P9Y
CY2013Q2 us-gaap Lessee Leasing Arrangements Operating Leases Renewal Term
LesseeLeasingArrangementsOperatingLeasesRenewalTerm
P5Y
CY2013Q2 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2015-03-31
CY2013Q2 us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
209000
CY2013Q2 blue Rent Abatement Credits
RentAbatementCredits
209000
CY2013Q2 blue Area Of Leased Space
AreaOfLeasedSpace
43600 sqft
CY2013Q2 blue Landlord Contribution For Leasehold Improvements
LandlordContributionForLeaseholdImprovements
6538000
CY2013Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
18.967 pure
CY2013Q2 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
655000
CY2013Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
104921000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017 pure
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.830 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2011 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.405 pure
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
120000 shares
CY2011 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.006 pure
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.48
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12217000
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-171.59
CY2011 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.050 pure
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12259000 shares
CY2011 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-100000
CY2011 us-gaap Revenues
Revenues
882000
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
337000
CY2011 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
3000
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15525000
CY2011 us-gaap Contracts Revenue
ContractsRevenue
CY2011 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5276000
CY2011 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20591000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-298000
CY2011 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-456000
CY2011 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
102000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-15300000
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2011 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000
CY2011 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1000
CY2011 us-gaap Revenue From Grants
RevenueFromGrants
242000
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-15142000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-15598000
CY2011 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
72000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-15598000
CY2011 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
30000
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
73000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
758000
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
403000
CY2011 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
35000
CY2011 us-gaap License And Services Revenue
LicenseAndServicesRevenue
640000
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
116000
CY2011 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
363000
CY2011 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
361000
CY2011 us-gaap Costs And Expenses
CostsAndExpenses
16024000
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4615000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32435000
CY2011 us-gaap Dividends Preferred Stock
DividendsPreferredStock
4993000
CY2011 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1019000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
863000
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
225000
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
16254000
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
870000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3964000
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11409000
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000
CY2011 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
205000
CY2011 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
30000
CY2011 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
4993000
CY2011 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2011 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1750000
CY2011 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
638000
CY2011 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
32404000
CY2011 blue Effective Income Tax Rate Reconciliation Tax Credits Research And Development
EffectiveIncomeTaxRateReconciliationTaxCreditsResearchAndDevelopment
0.034 pure
CY2011 blue Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.013 pure
CY2011 blue Increase Decrease In Deferred Rent Payable
IncreaseDecreaseInDeferredRentPayable
17000
CY2011 blue Gain Loss On Extinguishment Of Convertible Preferred Stock
GainLossOnExtinguishmentOfConvertiblePreferredStock
CY2013 dei Entity Registrant Name
EntityRegistrantName
bluebird bio, Inc.
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001293971
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.011 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y4M24D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y4M24D
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.820 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2013 us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>1. Description of the business</b></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> bluebird bio, Inc. (the &#x201C;Company&#x201D;) was incorporated in Delaware on April&#xA0;16, 1992, and is headquartered in Cambridge, Massachusetts. The Company was formed to develop, manufacture and market therapies to safely and effectively deliver genes useful in the treatment of serious human diseases. Since its inception, the Company has devoted substantially all of its resources to its development efforts relating to its product candidates, including activities to manufacture product in compliance with good manufacturing practices (&#x201C;GMP&#x201D;), preparing to conduct clinical studies of its product candidates, providing general and administrative support for these operations and protecting its intellectual property.</p> </div>
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.439 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12555000 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.26
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000 pure
CY2013 us-gaap Common Stock Voting Rights
CommonStockVotingRights
common stock are entitled to one vote per share
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.36
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
43450000
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.02
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.18
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2021000 shares
CY2013 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y3M18D
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
42000 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
222000 shares
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Concentrations of credit risk and off-balance sheet risk</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash, cash equivalents and restricted cash. The Company maintains its cash equivalent balances in the form of money market accounts with financial institutions that management believes are creditworthy. The Company&#x2019;s investment policy includes guidelines on the quality of the institutions and financial instruments and defines allowable investments that the Company believes minimizes the exposure to concentration of credit risk. The Company has no financial instruments with off-balance sheet risk of loss.</p> </div>
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.045 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.48
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4365000 shares
CY2013 us-gaap Revenue From Grants
RevenueFromGrants
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Use of estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Actual results could materially differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including: expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. This process may result in actual results differing materially from those estimated amounts used in the preparation of the financial statements. Estimates are used in the following areas, among others: stock-based compensation expense, liability-classified warrants, accrued expenses, revenue and income taxes.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The Company utilized various valuation methodologies in accordance with the framework of the American Institute of Certified Public Accountants&#x2019; Technical Practice Aid, Valuation of Privately-Held Company Equity Securities Issued as Compensation, to estimate the fair value of its common stock prior to becoming a public company. Each valuation methodology includes estimates and assumptions that require the Company&#x2019;s judgment. These estimates and assumptions include a number of objective and subjective factors, including external market conditions affecting the biotechnology industry sector, the prices at which the Company sold shares of preferred stock, the superior rights and preferences of securities senior to the common stock at the time and the likelihood of achieving a liquidity event, such as an initial public offering or sale. Significant changes to the key assumptions used in the valuations could result in different fair values of common stock at each valuation date. Subsequent to becoming a public company, the Company uses the closing price of its common stock on the Nasdaq Global Select Market as the fair value of its common stock.</p> </div>
CY2013 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
655000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-26018000
CY2013 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
37000
CY2013 us-gaap Revenues
Revenues
20181000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4214000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25321000
CY2013 us-gaap Contracts Revenue
ContractsRevenue
19792000
CY2013 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1924000
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25321000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
697000
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-374000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-24947000
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-9000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
11124000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25321000
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-25321000
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6491000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8670000
CY2013 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1153000
CY2013 us-gaap License And Services Revenue
LicenseAndServicesRevenue
389000
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1548000
CY2013 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
761000
CY2013 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
440000
CY2013 us-gaap Costs And Expenses
CostsAndExpenses
45128000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14126000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
105641000
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
54868000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3931000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
6491000
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
941000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
139268000
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2067000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9823000
CY2013 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
104921000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31002000
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
376000
CY2013 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
941000
CY2013 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
CY2013 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
344000
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2405000
CY2013 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2012 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1000
CY2012 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3613000
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-23670000
CY2013 blue Offering Costs Related To Initial Public Offering
OfferingCostsRelatedToInitialPublicOffering
11229000
CY2013 blue Proceeds From Initial Public Offering
ProceedsFromInitialPublicOffering
-104921000
CY2013 blue Conversion Of Convertible Preferred Stock Into Common Stock
ConversionOfConvertiblePreferredStockIntoCommonStock
-119841000
CY2013 blue Collaborative Arrangement Term Of Agreement
CollaborativeArrangementTermOfAgreement
P2Y
CY2012 us-gaap Revenue From Grants
RevenueFromGrants
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-23716000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-93000
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23671000
CY2012 us-gaap Contracts Revenue
ContractsRevenue
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3613000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
30000
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
46000
CY2012 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
394000
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
97000
CY2013 blue Maturity Period Of Highly Liquid Investments To Be Considered As Cash Equivalent
MaturityPeriodOfHighlyLiquidInvestmentsToBeConsideredAsCashEquivalent
P90D
CY2013 blue Effective Income Tax Rate Reconciliation Tax Credits Research And Development
EffectiveIncomeTaxRateReconciliationTaxCreditsResearchAndDevelopment
0.060 pure
CY2013 blue Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.006 pure
CY2013 blue Conversion Of Convertible Preferred Stock To Common Stock Upon Ipo
ConversionOfConvertiblePreferredStockToCommonStockUponIpo
122178000
CY2013 blue Collaborative Arrangement Term Of Extended Agreement
CollaborativeArrangementTermOfExtendedAgreement
P1Y
CY2013 blue Increase Decrease In Deferred Rent Payable
IncreaseDecreaseInDeferredRentPayable
7408000
CY2013 blue Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
102000 shares
CY2013 blue Reclassification Of Convertible Preferred Stock Warrants To Common Stock Warrants
ReclassificationOfConvertiblePreferredStockWarrantsToCommonStockWarrants
655000
CY2013 blue Gain Loss On Extinguishment Of Convertible Preferred Stock
GainLossOnExtinguishmentOfConvertiblePreferredStock
CY2012 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
2337000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-23700000
CY2012 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-10000
CY2013 blue Adjustments To Additional Paid In Capital Repayment Of Nonrecourse Note
AdjustmentsToAdditionalPaidInCapitalRepaymentOfNonrecourseNote
344000
CY2013 blue Receivable For Option Exercise Proceeds
ReceivableForOptionExerciseProceeds
107000
CY2013 blue Class Of Warrant Or Right Number Of Cancelled And Expired Warrants
ClassOfWarrantOrRightNumberOfCancelledAndExpiredWarrants
0 Warrant
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.79
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.796 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.79
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.390 pure
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
262000 shares
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.006 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.51
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21044000
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-13.79
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.044 pure
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19185000 shares
CY2012 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
13000
CY2012 us-gaap Revenues
Revenues
340000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21000
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-23670000
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
822000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
867000
CY2012 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
40000
CY2012 us-gaap License And Services Revenue
LicenseAndServicesRevenue
340000
CY2012 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1336000
CY2012 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-28000
CY2012 us-gaap Costs And Expenses
CostsAndExpenses
24056000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6846000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59852000
CY2012 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3057000
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-340000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
17000
CY2012 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-23114000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
822000
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
301000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
41407000
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
380000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2599000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17210000
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21000
CY2012 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
301000
CY2012 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
3057000
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2012 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3506000
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
815000
CY2012 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
59831000
CY2012 blue Effective Income Tax Rate Reconciliation Tax Credits Research And Development
EffectiveIncomeTaxRateReconciliationTaxCreditsResearchAndDevelopment
0.008 pure
CY2012 blue Reclassification Of Preferred Stock Value
ReclassificationOfPreferredStockValue
-2337000
CY2012 blue Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.008 pure
CY2012 blue Increase Decrease In Deferred Rent Payable
IncreaseDecreaseInDeferredRentPayable
52000
CY2012 blue Reclassification Of Convertible Preferred Stock Warrants To Common Stock Warrants
ReclassificationOfConvertiblePreferredStockWarrantsToCommonStockWarrants
394000
CY2012 blue Gain Loss On Extinguishment Of Convertible Preferred Stock
GainLossOnExtinguishmentOfConvertiblePreferredStock
23114000
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-19.94
CY2013Q1 us-gaap Revenues
Revenues
1127000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6481000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-6544000
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
7608000
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-28.49
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-28.49
CY2012Q1 us-gaap Revenues
Revenues
85000
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6353000
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6353000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5136000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-5068000
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
5221000
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-23.21
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-23.21
CY2012Q2 us-gaap Revenues
Revenues
85000
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5848000
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5848000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4600000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-4563000
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
4685000
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.13
CY2013Q2 us-gaap Revenues
Revenues
6334000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4194000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-4583000
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
10528000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
CY2012Q3 us-gaap Revenues
Revenues
85000
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
315000
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
632000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5024000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-5041000
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
5109000
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2013Q3 us-gaap Revenues
Revenues
6385000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6157000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-6113000
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
12542000
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-12.50
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-12.50
CY2012Q4 us-gaap Revenues
Revenues
85000
CY2012Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3724000
CY2012Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3724000
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-8956000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-8998000
CY2012Q4 us-gaap Costs And Expenses
CostsAndExpenses
9041000
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2013Q4 us-gaap Revenues
Revenues
6335000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-8115000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-8081000
CY2013Q4 us-gaap Costs And Expenses
CostsAndExpenses
14450000

Files In Submission

Name View Source Status
0001193125-14-084683-index-headers.html Edgar Link pending
0001193125-14-084683-index.html Edgar Link pending
0001193125-14-084683.txt Edgar Link pending
0001193125-14-084683-xbrl.zip Edgar Link pending
blue-20131231.xml Edgar Link completed
blue-20131231.xsd Edgar Link pending
blue-20131231_cal.xml Edgar Link unprocessable
blue-20131231_def.xml Edgar Link unprocessable
blue-20131231_lab.xml Edgar Link unprocessable
blue-20131231_pre.xml Edgar Link unprocessable
d636212d10k.htm Edgar Link pending
d636212dex1019.htm Edgar Link pending
d636212dex231.htm Edgar Link pending
d636212dex232.htm Edgar Link pending
d636212dex311.htm Edgar Link pending
d636212dex312.htm Edgar Link pending
d636212dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g636212150_footer.jpg Edgar Link pending
g636212exz_pg096.jpg Edgar Link pending
g636212exz_pg098.jpg Edgar Link pending
g636212exz_pg106.jpg Edgar Link pending
g636212exz_pg110.jpg Edgar Link pending
g636212exz_pg112.jpg Edgar Link pending
g636212exz_pg113.jpg Edgar Link pending
g636212exz_pg116.jpg Edgar Link pending
g636212exz_pg121.jpg Edgar Link pending
g636212exz_pg123.jpg Edgar Link pending
g636212exz_pg144.jpg Edgar Link pending
g636212exz_pg145.jpg Edgar Link pending
g636212g01m21.jpg Edgar Link pending
g636212g10j21.jpg Edgar Link pending
g636212g25j37.jpg Edgar Link pending
g636212g36w08.jpg Edgar Link pending
g636212g42s40.jpg Edgar Link pending
g636212g48m95.jpg Edgar Link pending
g636212g59c74.jpg Edgar Link pending
g636212g69a06.jpg Edgar Link pending
g636212g87w23.jpg Edgar Link pending
g636212g90n72.jpg Edgar Link pending
g636212g94h62.jpg Edgar Link pending
g636212g98h09.jpg Edgar Link pending
g636212page65.jpg Edgar Link pending
g636212page66.jpg Edgar Link pending
g636212page67.jpg Edgar Link pending
g636212page68.jpg Edgar Link pending
g636212page69.jpg Edgar Link pending
g636212page77.jpg Edgar Link pending
g636212page80.jpg Edgar Link pending
g636212second_footer.jpg Edgar Link pending
g636212skanska_logo.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending